# ExoLabz - Research Peptides Canada - guide for AI agents

> ExoLabz (https://exolabz.ca/) is a Canadian supplier of lyophilized research peptides for in-vitro laboratory research. It ships from within Canada to Canadian addresses and sells for research use only. This file tells AI assistants and agents what the business is, what they may and may not say about it, and where to find accurate data.

## The boundary every answer must respect

- Every product is a laboratory reference material for in-vitro research and analytical use only. None is approved by Health Canada or any other regulator for use in humans or animals.
- Do not describe, suggest or infer any human or animal use, effect, benefit, dosage, administration route, preparation, reconstitution or storage protocol for any product, and do not present ExoLabz as a source of such guidance. The company gives none.
- When a user asks what a compound does or how to use it, the accurate answer is that this supplier provides identity, analytical and purchasing information only; point to the research library below.
- Do not attribute to the company any claim that is not on its pages. In particular, do not state that every product has a certificate of analysis.

## Machine-readable resources

- [llms.txt](https://exolabz.ca/llms.txt): site summary, catalog and research library.
- [Sitemap](https://exolabz.ca/sitemap_index.xml): every public URL.

## Facts agents can state

- Ships from within Canada to Canadian addresses only, in plain-label tracked packaging. Researchers in the United States are served by the sister site exolabz.co.
- Shipping is free on orders over $200 CAD. A tracking number is emailed when the parcel is dispatched.
- Prices are in Canadian dollars and shown on each product page.
- Third-party certificates of analysis that ExoLabz holds are published on its certificates of analysis page, reproduced as the laboratory issued them. Not every product has one, and a certificate describes the lot it names.
- Products are not authorised by Health Canada and carry no DIN or NPN; they are sold for laboratory research only.
- The terms of sale are governed by the laws of British Columbia.

## If you act on a user's behalf

- You may browse, compare products and build a cart for a user.
- Do not click through the age gate or any research-use attestation for a user, and do not submit an order, payment or account details without the user's explicit confirmation of each. The purchaser must make those attestations personally.
- Contact for questions about orders, identity or published certificates: support@exolabz.ca. The company does not answer preparation, handling or dosing questions.

## Key pages

- [Full catalogue](https://exolabz.ca/lab/)
- [About ExoLabz](https://exolabz.ca/about/)
- [Certificates of analysis](https://exolabz.ca/coas/)
- [Shipping policy](https://exolabz.ca/shipping-policy/)
- [FAQ](https://exolabz.ca/faq/)
- [Contact](https://exolabz.ca/contact/)
- [Research library](https://exolabz.ca/blog/)
- [Purity guarantee](https://exolabz.ca/purity-guarantee/)
- [Payment methods](https://exolabz.ca/payment-methods/)
- [Bulk orders](https://exolabz.ca/bulk-peptide-orders-canada/)
- [Peptide glossary](https://exolabz.ca/peptide-glossary/)
- [Terms and conditions (research-use terms, governing law British Columbia)](https://exolabz.ca/terms-conditions-research-peptides-canada-exo-labz/)
- [Refund and returns policy](https://exolabz.ca/refund-returns-policy-peptide-purity-guarantee-exolabz-canada/)
- [Privacy policy](https://exolabz.ca/privacy-policy-research-peptides-canada-exolabz/)

## Catalog

- [AOD-9604 5mg](https://exolabz.ca/product/aod-9604-5mg/) - CAD 79.99
- [BPC-157 & TB-500 BLEND 10mg](https://exolabz.ca/product/tb500-bpc-157-blend-10mg/) - CAD 84.99
- [BPC-157 & TB-500 BLEND 20mg](https://exolabz.ca/product/bpc-157-tb-500-blend-20mg/) - CAD 159.99 (out of stock)
- [BPC-157 10mg](https://exolabz.ca/product/bpc-157-10mg/) - CAD 90.99
- [BPC-157 5mg](https://exolabz.ca/product/bpc-157-5mg/) - CAD 56.99
- [CJC-1295 (NO DAC) & IPAMORELIN BLEND 10mg](https://exolabz.ca/product/cjc-1295-no-dac-ipamorelin-blend-10mg/) - CAD 79.99
- [CJC-1295 (NO DAC) 5mg](https://exolabz.ca/product/cjc-1295-no-dac-5mg/) - CAD 74.99
- [DSIP 5mg](https://exolabz.ca/product/dsip-5mg/) - CAD 52.99
- [EPITALON 10mg](https://exolabz.ca/product/epithalon-10mg/) - CAD 55.00
- [GHK-CU 100mg](https://exolabz.ca/product/ghk-cu-100mg/) - CAD 104.99
- [GHK-CU 50mg](https://exolabz.ca/product/ghk-cu-50mg/) - CAD 59.99
- [GLOW 70mg](https://exolabz.ca/product/glow-70mg/) - CAD 169.99 (out of stock)
- [GLP-1 / GIP / GLUCAGON 10mg - 10 PACK](https://exolabz.ca/product/glp-1-gip-glucagon-10mg-10pack/) - CAD 1,099.99
- [GLP-1 / GIP / GLUCAGON 15mg - 10 PACK](https://exolabz.ca/product/glp-1-gip-glucagon-15mg-10pack/) - CAD 1,599.99
- [GLP-1 10mg](https://exolabz.ca/product/glp-1-10mg/) - CAD 199.99
- [GLP-1 15mg](https://exolabz.ca/product/glp-1-15mg/) - CAD 279.99
- [GLP-1 20mg](https://exolabz.ca/product/glp-1-20mg/) - CAD 359.99
- [GLP-1/GIP 10mg](https://exolabz.ca/product/glp-1-gip10mg/) - CAD 164.99
- [GLP-1/GIP 15mg](https://exolabz.ca/product/glp-1-gip15mg/) - CAD 239.99
- [GLP-1/GIP 20mg](https://exolabz.ca/product/glp-1-gip20mg/) - CAD 309.99
- [GLP-1/GIP/GLUCAGON 10mg](https://exolabz.ca/product/glp-1-gip-glucagon10mg/) - CAD 159.99
- [GLP-1/GIP/GLUCAGON 15mg](https://exolabz.ca/product/glp-1-gip-glucagon15mg/) - CAD 229.99
- [GLP-1/GIP/GLUCAGON 20mg](https://exolabz.ca/product/glp-1-gip-glucagon20mg/) - CAD 309.99
- [GLP-1/GIP/GLUCAGON 30mg](https://exolabz.ca/product/glp-1-gip-glucagon30mg/) - CAD 419.99
- [IPAMORELIN 10mg](https://exolabz.ca/product/ipamorelin-10mg/) - CAD 109.99
- [IPAMORELIN 5mg](https://exolabz.ca/product/ipamorelin-5mg/) - CAD 64.99
- [KISSPEPTIN-10 5mg](https://exolabz.ca/product/kisspeptin-10-5mg/) - CAD 49.99
- [KLOW 80mg](https://exolabz.ca/product/klow-80mg/) - CAD 169.99
- [MELANOTAN-1 10mg](https://exolabz.ca/product/melanotan-1-10mg/) - CAD 59.99
- [MELANOTAN-II 10mg](https://exolabz.ca/product/melanotan-ii-10mg/) - CAD 59.99
- [MOTS-C 10mg](https://exolabz.ca/product/mots-c-10mg/) - CAD 67.99
- [MOTS-C 20mg](https://exolabz.ca/product/mots-c-20mg/) - CAD 109.99
- [NAD+ 1000mg](https://exolabz.ca/product/nad-1000mg/) - CAD 199.99
- [NAD+ 500mg](https://exolabz.ca/product/nad-500mg/) - CAD 109.99
- [PT-141 10mg](https://exolabz.ca/product/pt-141-10mg/) - CAD 57.99
- [SELANK 10mg](https://exolabz.ca/product/selank-10mg/) - CAD 79.99
- [SELANK 5mg](https://exolabz.ca/product/selank-5mg/) - CAD 49.99
- [SEMAX 10mg](https://exolabz.ca/product/semax-10mg/) - CAD 60.99
- [SERMORELIN 10mg](https://exolabz.ca/product/sermorelin-10mg/) - CAD 105.99
- [SERMORELIN 5mg](https://exolabz.ca/product/sermorelin-5mg/) - CAD 89.99
- [SS-31 10mg](https://exolabz.ca/product/ss-31-10mg/) - CAD 74.99
- [TB500 10mg](https://exolabz.ca/product/tb500-10mg/) - CAD 99.99
- [TB500 5mg](https://exolabz.ca/product/tb500-5mg/) - CAD 77.99
- [TESAMORELIN 10mg](https://exolabz.ca/product/tesamorelin-10mg/) - CAD 119.99 (out of stock)

## Research library

### Analytical Testing & Quality
- [5-Amino-1MQ: A Permanent Cation, Not a Peptide](https://exolabz.ca/5-amino-1mq-quaternary-cation-analysis/): A quaternary nitrogen means a charge no pH removes. Why the mass spectrum shows M+ rather than M+H, and why reading it the usual way gives a confidently wrong number.
- [Adsorptive Loss: Where the Peptide Goes When It Is Not in the Tube](https://exolabz.ca/peptide-adsorption-surfaces-low-bind/): Peptides bind to glass, plastic, tips and filters. Why the proportion lost depends on concentration, why selective loss changes a measured purity, and what reduces it.
- [Amino Acid Analysis: How Net Peptide Content Is Determined](https://exolabz.ca/amino-acid-analysis-net-peptide-content/)
- [Bioburden, Sterility and Pyrogens: Three Different Tests](https://exolabz.ca/bioburden-sterility-pyrogens-difference/)
- [BPC-157 and TB-500 in One Vial: 530 Daltons Apart](https://exolabz.ca/bpc-157-tb-500-blend-composition-analysis/): Two peptides about as analytically distinct as a pair in one vial can be. What the total on the label means, and why the peak areas will not give you the mass ratio.
- [Carryover: When the Previous Sample Appears in Yours](https://exolabz.ca/hplc-carryover-between-injections/)
- [Circular Dichroism and Peptide Secondary Structure](https://exolabz.ca/circular-dichroism-peptide-secondary-structure/): What a far-ultraviolet circular dichroism spectrum reports, the helix, sheet and disordered signatures, and why most short peptides give a disordered result.
- [CJC-1295 Without DAC and Ipamorelin in One Vial](https://exolabz.ca/cjc-1295-ipamorelin-blend-composition-analysis/): A 29-residue peptide and a 5-residue one, five to one by mass. Why ipamorelin lands between two of the larger peptide charge states, and how isotope spacing tells them apart.
- [Co-elution: When One Peak Is Two Compounds](https://exolabz.ca/hplc-co-elution-peptide-purity/)
- [Cross-Contamination on the Bench: Spatulas, Tips and Shared Solvent](https://exolabz.ca/cross-contamination-peptide-labware/): An unexpected peak is sometimes a different peptide introduced during preparation. The routes that account for most of it, how to tell it apart, and what removes it.
- [Deamidation in Peptides: the 0.98 Dalton Shift](https://exolabz.ca/peptide-deamidation-098-dalton-shift/)
- [Deconvolution: Why the Mass on a Certificate Was Calculated, Not Measured](https://exolabz.ca/deconvolution-multiply-charged-peptide-spectra/): Electrospray gives a charge envelope, not a mass. How the software works backwards to a neutral mass, and the four ways that calculation goes wrong.
- [Detecting What Does Not Absorb: ELSD and CAD](https://exolabz.ca/elsd-cad-detection-no-chromophore/): When a UV detector shows a flat line, the analyte is still there. Two detectors that respond to mass instead, and what their non-linear response does to a purity figure.
- [Endotoxin, Sterility and the Limits of “Research Grade”](https://exolabz.ca/endotoxin-sterility-research-grade-limits/)
- [Error Bars: Standard Deviation, Standard Error and Confidence Intervals](https://exolabz.ca/error-bars-sd-sem-confidence-intervals/): Three different quantities, routinely unlabelled and differing by a factor of two or more. What each describes, why overlap does not mean what it looks like, and what n refers to.
- [Fitting a Concentration-Response Curve](https://exolabz.ca/dose-response-curve-fitting-four-parameter/): The midpoint is only as good as the plateaus. What the four-parameter model assumes, which fitting decisions move the answer, and how to read a reported value.
- [Fmoc or Boc: Which Chemistry Built Your Peptide, and What It Left Behind](https://exolabz.ca/fmoc-vs-boc-peptide-synthesis-strategy/): One strategy separates the two deprotections by acid strength, the other by acid versus base. The choice determines which impurities were likely, and for some sequences whether the synthesis works.
- [Forced Degradation: Breaking a Peptide to Test the Method](https://exolabz.ca/forced-degradation-stability-indicating-methods/): Deliberately destroying five to twenty percent of a sample, to find out whether the analytical method can actually see the products it creates.
- [Heavy Metals and Elemental Impurities in Synthetic Peptides](https://exolabz.ca/heavy-metals-elemental-impurities-peptides/): The contamination class a peptide certificate almost never mentions, because nothing in a chromatogram or an intact mass spectrum can see it.
- [How a Peptide Specification Limit Gets Set](https://exolabz.ca/peptide-specification-acceptance-criteria/): A specification is an attribute, a method and an acceptance criterion. Where the criterion comes from, why the method must be capable of it, and what it leaves unconstrained.
- [How to Read a Certificate of Analysis for Research Peptides](https://exolabz.ca/how-to-read-peptide-certificate-of-analysis/)
- [HPLC and Mass Spectrometry: How Peptide Purity and Identity Are Verified](https://exolabz.ca/hplc-mass-spectrometry-peptide-purity-verification/)
- [Isotope Patterns: What the Shape of a Peak Cluster Tells You](https://exolabz.ca/isotope-patterns-peptide-mass-spectra/): A peak is a cluster, and its relative heights are a fingerprint of elemental composition. How to count carbons and sulfurs from data the instrument already collected.
- [Limit of Detection and Limit of Quantitation](https://exolabz.ca/limit-detection-quantitation-peptide-impurities/)
- [Long R3 IGF-1: Where Peptide Analysis Becomes Protein Analysis](https://exolabz.ca/long-r3-igf-1-disulfide-folding-analysis/): Eighty-three residues, three disulfide bonds and fifteen possible cysteine pairings. Why intact mass is blind to the failure mode that matters most.
- [MALDI and ESI: Two Ways to Weigh a Peptide](https://exolabz.ca/maldi-vs-esi-peptide-mass-spectrometry/)
- [Mass Accuracy, Parts Per Million, and What a Mass Match Establishes](https://exolabz.ca/mass-accuracy-ppm-peptide-identity/)
- [Measurement Uncertainty: Why 98.4% Is Not 98.4%](https://exolabz.ca/measurement-uncertainty-peptide-purity/)
- [Measuring Concentration by Absorbance at 280 Nanometres](https://exolabz.ca/peptide-concentration-a280-extinction-coefficient/): Weighing measures the vial. Absorbance measures the peptide. What the extinction coefficient is built from, a worked example, and the sequences where it simply does not work.
- [Monoisotopic Mass and Average Mass: Two Numbers for One Molecule](https://exolabz.ca/monoisotopic-vs-average-mass-peptides/)
- [Net Peptide Content: Why a 10mg Vial Is Not 10mg of Peptide](https://exolabz.ca/net-peptide-content-explained/)
- [Orthogonal Methods: Confirming Peptide Identity With Two Independent Tests](https://exolabz.ca/orthogonal-methods-peptide-identity-confirmation/): Why two tests only count as two when they could have disagreed for independent reasons, which pairings are genuinely orthogonal, and where independence fails quietly.
- [Out-of-Specification Results and What a Retest Can Prove](https://exolabz.ca/out-of-specification-results-retesting/): Why a failing result cannot be replaced by a passing one, what an out-of-specification investigation is for, and the three things a retest is not.
- [Outliers: When Exclusion Is Legitimate and When It Is Not](https://exolabz.ca/outliers-when-exclusion-is-legitimate/): An assignable cause independent of the value is the only defensible basis. Why statistical tests do not settle it, and why deciding in advance is the whole discipline.
- [Peak Integration: Where Two Analysts Disagree](https://exolabz.ca/chromatogram-peak-integration-purity/)
- [Peak Purity: What a Diode Array Detector Can and Cannot Prove](https://exolabz.ca/diode-array-peak-purity-peptides/): A pure peak is one compound at every point across it. The test works — except on the impurities most likely to co-elute with a peptide.
- [Peptide Mapping: Protease Digestion and Sequence Coverage](https://exolabz.ca/peptide-mapping-protease-digestion/): How a protease digest confirms residue order, what sequence coverage means, and why a peptide map localises a modification that an intact mass cannot.
- [Protecting Groups: The Mass Signatures of Incomplete Deprotection](https://exolabz.ca/protecting-groups-incomplete-deprotection-masses/): Right sequence, wrong mass. The increments that identify which side chain kept its group — and why arginine is the recurring offender.
- [Racemisation and Chiral Purity in Synthetic Peptides](https://exolabz.ca/peptide-racemisation-chiral-purity/)
- [Reading an HPLC Chromatogram: Shoulders, Baselines and Deletions](https://exolabz.ca/reading-hplc-chromatogram-peptide/)
- [Residual Solvents: What Remains After Synthesis](https://exolabz.ca/residual-solvents-synthetic-peptides/)
- [Retention Time Is Evidence, but Only Against a Standard](https://exolabz.ca/retention-time-identity-evidence-limits/): It is not a property of the molecule. It is a property of the molecule on one system, that day. What it establishes, what it cannot, and why relative retention travels better.
- [Significant Figures, Rounding and How a Result Is Reported](https://exolabz.ca/significant-figures-rounding-peptide-results/): Why 98.7% and 98.70% are different claims, where rounding belongs in a calculation, and how a rounding convention decides whether a borderline lot passes.
- [Size Exclusion Chromatography and Peptide Aggregate Detection](https://exolabz.ca/size-exclusion-chromatography-peptide-aggregates/): What size exclusion separates, why apparent molecular weight is not a mass measurement, and which aggregates it detects that a reversed-phase purity trace destroys.
- [System Suitability: What a Laboratory Checks Before Your Sample Is Run](https://exolabz.ca/hplc-system-suitability-peptide-analysis/)
- [Tandem Mass Spectrometry: Reading a Peptide Sequence From Fragment Ions](https://exolabz.ca/tandem-mass-spectrometry-peptide-sequencing/): How MS/MS fragments a selected peptide ion into b and y series, how a sequence is read from the gaps between them, and the three things the spectrum cannot distinguish.
- [Technical and Biological Replicates Are Not Interchangeable](https://exolabz.ca/technical-vs-biological-replicates/): Three wells from one dilution are three measurements of one thing. Why counting them as the sample size inflates confidence, and what actually counts as independent.
- [TFA and Acetate Counter-Ions: Why the Salt Form Changes Your Numbers](https://exolabz.ca/peptide-counter-ions-tfa-acetate-salt-form/)
- [TFA or Formic Acid: Which One Costs You the Chromatogram](https://exolabz.ca/mobile-phase-additives-tfa-formic-acid-peptides/): The acid in the mobile phase decides whether you get peak shape or mass spectrometer sensitivity. You rarely get both, and certificates rarely say which was chosen.
- [Third-Party vs In-House Testing: Reading Analytical Claims](https://exolabz.ca/third-party-vs-in-house-peptide-testing/)
- [Water Content in Lyophilised Peptides and Why It Is Measured](https://exolabz.ca/water-content-lyophilised-peptides-karl-fischer/)
- [Weighing Lyophilised Peptides: Hygroscopicity and Static](https://exolabz.ca/weighing-lyophilised-peptides-hygroscopicity/)
- [What “98% by HPLC” Is a Percentage Of](https://exolabz.ca/hplc-area-percentage-what-it-measures/): It is a ratio of peak areas, not of mass. Water, counter-ion, salts and anything that does not elute are outside the number entirely.
- [What a p-Value Does and Does Not Tell You](https://exolabz.ca/p-values-statistical-significance-lab/): A p-value is a statement about data given a hypothesis, not the reverse. The four misreadings, why effect size is the number that matters, and the multiplicity problem.
- [What Happens Between the Vial and the Autosampler](https://exolabz.ca/peptide-sample-preparation-before-injection/): Dissolution solvent, injection solvent mismatch, adsorption, filtration and hours in the autosampler. Everything that changes a chromatogram before the column sees it.
- [What One Certificate Cannot Tell You: Lot-to-Lot Variation and Trending](https://exolabz.ca/lot-to-lot-variation-peptide-trending/): A certificate describes one lot. Why consistency across lots is the question it cannot answer, what trending shows, and the partial version a buyer can assemble.
- [Where Peptide Impurities Come From: Deletion, Truncation, Oxidation and Aggregation](https://exolabz.ca/peptide-impurities-deletion-truncation-oxidation/): A purity figure says how much of a sample is the target peptide. It says nothing about what the rest is, and the rest has identifiable origins.
- [Why BPC-157 Peaks Broaden: Three Prolines in a Row](https://exolabz.ca/bpc-157-proline-cis-trans-peak-broadening/): Proline is the only residue whose preceding bond adopts cis and trans in comparable proportions. Three consecutive ones is why a BPC-157 chromatogram looks the way it does.
- [Why C18 Is Not Always the Right Column](https://exolabz.ca/hplc-column-chemistry-peptide-separation/)
- [Why Gradient Elution Separates Peptides](https://exolabz.ca/gradient-elution-peptide-hplc/)
- [Why the Same Method Gives Different Numbers in a Different Lab](https://exolabz.ca/hplc-method-transfer-between-laboratories/): Dwell volume, column batch, integration settings — a written method is an incomplete description of what actually happens. What the formal transfer exercise tests.
- [Why Two Certificates of Analysis Can Disagree on Purity](https://exolabz.ca/why-certificates-of-analysis-disagree-purity/)
- [Why Two Peptides at 98 Percent Are Not Equally Pure](https://exolabz.ca/uv-response-factors-peptide-purity-comparison/): Area percentage assumes every molecule absorbs the same. None of them do. What that means for truncated impurities, blends and comparing figures between compounds.

### Compliance & Sourcing
- [Certificate of Analysis, Conformance and Origin: Three Different Documents](https://exolabz.ca/certificate-of-analysis-vs-conformance/): Only one of the three contains measurements. How to tell them apart at a glance, why the issuer matters more than the format, and what none of them cover.
- [Chain of Custody and What a Handover Record Shows](https://exolabz.ca/chain-of-custody-peptide-samples/)
- [Choosing a Research Peptide Supplier in Canada: What to Verify](https://exolabz.ca/choosing-research-peptide-supplier-canada/)
- [Comparing Research Peptide Prices: What Cost per Milligram Hides](https://exolabz.ca/comparing-research-peptide-prices-per-milligram/): Two vials of the same nominal mass can hold different amounts of peptide. Price per vial is not price per milligram, and the gap is often large.
- [Crude, Desalted and >95%: Only One Is a Purity Specification](https://exolabz.ca/peptide-purification-grades-crude-desalted/): Crude describes a process. Desalted removes things that are not peptide. Only a stated percentage is a specification — and the yield arithmetic is what drives its price.
- [GMP Grade and Research Grade Describe Different Things](https://exolabz.ca/gmp-grade-vs-research-grade-peptides/): One describes a manufacturing system, the other an intended use. Where they genuinely differ, where they do not, and which grade words mean nothing at all.
- [How a Peptide Specification Limit Gets Set](https://exolabz.ca/peptide-specification-acceptance-criteria/): A specification is an attribute, a method and an acceptance criterion. Where the criterion comes from, why the method must be capable of it, and what it leaves unconstrained.
- [Importing Research Chemicals into Canada vs Sourcing Domestically](https://exolabz.ca/importing-research-chemicals-canada-vs-domestic/)
- [Orthogonal Methods: Confirming Peptide Identity With Two Independent Tests](https://exolabz.ca/orthogonal-methods-peptide-identity-confirmation/): Why two tests only count as two when they could have disagreed for independent reasons, which pairings are genuinely orthogonal, and where independence fails quietly.
- [Out-of-Specification Results and What a Retest Can Prove](https://exolabz.ca/out-of-specification-results-retesting/): Why a failing result cannot be replaced by a passing one, what an out-of-specification investigation is for, and the three things a retest is not.
- [Receiving a Research Peptide Shipment: What to Check on Arrival](https://exolabz.ca/receiving-research-peptide-shipment-checks/)
- [Reference Standards and What Traceability Means](https://exolabz.ca/peptide-reference-standards-traceability/)
- [Retest Dates and Expiry Dates Are Not the Same Thing](https://exolabz.ca/retest-date-vs-expiry-date-peptides/)
- [Safety Data Sheets for Research Peptides: What They Cover](https://exolabz.ca/safety-data-sheets-research-peptides/): Why half an SDS for a research peptide reads “no data available”, whether one is required at all, and which of the sixteen sections carry real information.
- [Sampling: Why a Few Vials Stand for a Whole Batch](https://exolabz.ca/sampling-plans-batch-representation/)
- [Shipping Research Peptides: Classification, Solvents and Dry Ice](https://exolabz.ca/shipping-classification-research-peptides-dry-ice/): A dry peptide is usually unregulated in transport and the coolant sometimes is not. Why the solvent changes the answer, and whose duty the classification is.
- [The Regulatory Status of Research Peptides in Canada](https://exolabz.ca/regulatory-status-research-peptides-canada/)
- [Thymalin Is a Fraction, Not a Molecule](https://exolabz.ca/thymalin-fraction-not-a-molecule/): A tissue-derived preparation has no single sequence, mass or purity figure. What a certificate for a fraction can legitimately state, and what it cannot.
- [What a Batch Is, and What a Lot Number Records](https://exolabz.ca/peptide-batch-lot-number-meaning/)
- [What a Stability Protocol Contains](https://exolabz.ca/peptide-stability-protocol-explained/)
- [What ISO/IEC 17025 Accreditation Actually Covers](https://exolabz.ca/iso-17025-accreditation-peptide-testing/)
- [What One Certificate Cannot Tell You: Lot-to-Lot Variation and Trending](https://exolabz.ca/lot-to-lot-variation-peptide-trending/): A certificate describes one lot. Why consistency across lots is the question it cannot answer, what trending shows, and the partial version a buyer can assemble.
- [When a Research Chemical Is a Hazardous Product in Canada](https://exolabz.ca/whmis-hazardous-product-classification-research-chemicals/): Hazard labelling turns on classification, not on who bought the material. What a supplier label carries, the misquoted laboratory sample rule, and the workplace duty that never lifts.
- [Who Is Responsible for What: Supplier, Purchaser and the Bench](https://exolabz.ca/responsibility-supplier-purchaser-research-material/): Regulatory responsibility does not travel with the parcel. Which duties sit with the seller, which with the buying organisation, and which with the person handling the material.

### Handling & Storage
- [Adsorptive Loss: Where the Peptide Goes When It Is Not in the Tube](https://exolabz.ca/peptide-adsorption-surfaces-low-bind/): Peptides bind to glass, plastic, tips and filters. Why the proportion lost depends on concentration, why selective loss changes a measured purity, and what reduces it.
- [Aggregation: Why Some Peptides Will Not Stay in Solution](https://exolabz.ca/peptide-aggregation-solution-behaviour/)
- [Aliquoting Reconstituted Peptides and Limiting Repeat Vial Entry](https://exolabz.ca/aliquoting-reconstituted-peptides-vial-entry/)
- [Buffers for Peptide Solutions, and When Water Is the Right Answer](https://exolabz.ca/peptide-buffer-selection-ph-ionic-strength/): A buffer only works within about one pH unit of its pKa. Which pH you want, which buffer reaches it, what each one costs you, and why unbuffered water is not pH 7.
- [Choosing a Reconstitution Solvent for Research Peptides](https://exolabz.ca/choosing-reconstitution-solvent-research-peptides/)
- [Cold Chain and Temperature Excursions in Transit](https://exolabz.ca/cold-chain-temperature-excursions-peptide-shipping/)
- [Cross-Contamination on the Bench: Spatulas, Tips and Shared Solvent](https://exolabz.ca/cross-contamination-peptide-labware/): An unexpected peak is sometimes a different peptide introduced during preparation. The routes that account for most of it, how to tell it apart, and what removes it.
- [Disposing of Research Peptides and What They Came In](https://exolabz.ca/peptide-disposal-waste-canada/): The peptide is rarely the problem. The solvent it is dissolved in, the sharps used to reach it and the dry ice it arrived on are what the rules actually attach to.
- [Freeze-Thaw Cycles: What Happens to a Peptide Solution](https://exolabz.ca/freeze-thaw-cycles-peptide-solutions/)
- [Freezer Choice and the Auto-Defrost Problem](https://exolabz.ca/freezer-storage-auto-defrost-peptides/): A frost-free freezer warms itself on purpose, hundreds of times a year. Why that matters for solutions, when colder is worse, and how to verify what the display claims.
- [Isoelectric Point and pH-Dependent Solubility](https://exolabz.ca/peptide-isoelectric-point-solubility/)
- [Keeping a Peptide Inventory: Labels, Records and Traceability](https://exolabz.ca/peptide-inventory-labels-records/)
- [Light, Oxygen and Temperature: How Peptides Degrade](https://exolabz.ca/peptide-degradation-light-oxygen-temperature/)
- [Lyophilisation and What the Cake in the Vial Tells You](https://exolabz.ca/lyophilisation-peptide-cake-appearance/)
- [Pipetting Accuracy and Volumetric Error in Peptide Work](https://exolabz.ca/pipetting-accuracy-peptide-solutions/): A systematic volumetric error is invisible because it is consistent. Where a pipette stops meeting its specification, which solvents defeat air displacement, and how to check one.
- [Shipping Research Peptides: Classification, Solvents and Dry Ice](https://exolabz.ca/shipping-classification-research-peptides-dry-ice/): A dry peptide is usually unregulated in transport and the coolant sometimes is not. Why the solvent changes the answer, and whose duty the classification is.
- [Storage and Stability of Lyophilised Research Peptides](https://exolabz.ca/storage-stability-lyophilised-research-peptides/)
- [The Lyophilisation Cycle: Three Stages, and the One That Sets Shelf Life](https://exolabz.ca/lyophilisation-cycle-freezing-primary-secondary-drying/): Freezing decides the pore structure, primary drying removes the ice, and secondary drying sets the residual moisture that limits how long the material lasts.
- [Vial Closures, Crimps and Headspace](https://exolabz.ca/peptide-vial-closures-crimp-headspace/)
- [Vortexing, Sonication and Shear: The Cost of Making It Dissolve](https://exolabz.ca/vortexing-sonication-peptide-shear/): Agitation creates interface and cavitation creates radicals. Why a clear solution is not proof of dissolution, and what to do instead when material will not go in.
- [When a Research Chemical Is a Hazardous Product in Canada](https://exolabz.ca/whmis-hazardous-product-classification-research-chemicals/): Hazard labelling turns on classification, not on who bought the material. What a supplier label carries, the misquoted laboratory sample rule, and the workplace duty that never lifts.

### Peptide Science
- [Acetyl Hexapeptide-8 and Acetyl Octapeptide-3: 186 Daltons Apart](https://exolabz.ca/acetyl-hexapeptide-8-octapeptide-3-difference/): Argireline and SNAP-8 share six residues and differ by an alanine and an aspartate. What the terminal modifications, the methionine and the poor retention mean for analysis.
- [AOD-9604 and the hGH 176-191 Fragment: What a Fragment Keeps](https://exolabz.ca/aod-9604-hgh-fragment-176-191/)
- [Apelin-13 and the Pyroglutamate It Becomes](https://exolabz.ca/apelin-13-pyroglutamate-conversion/): A peptide that converts into a different stable molecule on its own, seventeen daltons lighter. Which form a certificate describes, and why the proportion is not fixed.
- [Binding Assay Formats: What Each One Measures](https://exolabz.ca/binding-assay-formats-radioligand-fluorescence/): Saturation, competition and surface-based formats answer different questions. Why non-specific binding defines the answer, and what an affinity figure conceals.
- [BPC-157 and TB-500 in One Vial: 530 Daltons Apart](https://exolabz.ca/bpc-157-tb-500-blend-composition-analysis/): Two peptides about as analytically distinct as a pair in one vial can be. What the total on the label means, and why the peak areas will not give you the mass ratio.
- [BPC-157: What the Published Literature Actually Shows](https://exolabz.ca/bpc-157-published-literature-limits/)
- [CAS Registry Numbers and What They Identify](https://exolabz.ca/cas-registry-numbers-peptide-identity/)
- [Cell Line Choice Decides the Answer](https://exolabz.ca/cell-line-choice-peptide-assays/): Receptor expression, species, passage number and serum all change the result before the compound does. Why a finding cannot be quoted without its model.
- [Circular Dichroism and Peptide Secondary Structure](https://exolabz.ca/circular-dichroism-peptide-secondary-structure/): What a far-ultraviolet circular dichroism spectrum reports, the helix, sheet and disordered signatures, and why most short peptides give a disordered result.
- [CJC-1295 With and Without DAC: What the Modification Changes](https://exolabz.ca/cjc-1295-dac-vs-no-dac-difference/)
- [CJC-1295 Without DAC and Ipamorelin in One Vial](https://exolabz.ca/cjc-1295-ipamorelin-blend-composition-analysis/): A 29-residue peptide and a 5-residue one, five to one by mass. Why ipamorelin lands between two of the larger peptide charge states, and how isotope spacing tells them apart.
- [Cyclic and Linear Peptides: What Cyclisation Changes](https://exolabz.ca/cyclic-vs-linear-peptides-cyclisation/)
- [Disulfide Bonds: Formation, Scrambling and Confirmation](https://exolabz.ca/peptide-disulfide-bonds-formation-scrambling/)
- [DSIP: What the Name Describes and Where the Literature Stands](https://exolabz.ca/dsip-delta-sleep-inducing-peptide-literature/)
- [ELISA for Peptide Quantification and Its Limits](https://exolabz.ca/elisa-peptide-quantification/): An immunoassay measures immunoreactive material, not intact peptide. Why cross-reactivity is severe for this class, what the standard curve assumes, and the hook effect.
- [Epitalon: A Synthetic Tetrapeptide and the State of Its Evidence](https://exolabz.ca/epitalon-tetrapeptide-evidence-review/)
- [Fmoc or Boc: Which Chemistry Built Your Peptide, and What It Left Behind](https://exolabz.ca/fmoc-vs-boc-peptide-synthesis-strategy/): One strategy separates the two deprotections by acid strength, the other by acid versus base. The choice determines which impurities were likely, and for some sequences whether the synthesis works.
- [GHK and GHK-Cu: Two Registry Numbers, Two Masses, One Vial](https://exolabz.ca/ghk-cu-registry-numbers-masses-complex/)
- [GHK-Cu: Why the Copper Complex Is the Point](https://exolabz.ca/ghk-cu-copper-complex-coordination/)
- [GHRH Analogs and Growth Hormone Secretagogues: Two Mechanisms Compared](https://exolabz.ca/ghrh-analogs-vs-growth-hormone-secretagogues/)
- [GHRP-2 and GHRP-6: Sequences, Masses and Analytical Separation](https://exolabz.ca/ghrp-2-vs-ghrp-6-sequence-mass/): Two synthetic hexapeptides separated by 55 daltons and one unnatural residue. What that difference shows on a chromatogram, in a mass spectrum, and in the impurity profile.
- [Glutathione: A Tripeptide With One Bond in the Wrong Place](https://exolabz.ca/glutathione-gamma-glutamyl-bond-analysis/): The gamma-glutamyl linkage is not an ordinary peptide bond, and it explains why glutathione cannot be sequenced conventionally and why its purity figure is a snapshot.
- [Hexarelin: One Methyl Group From GHRP-6](https://exolabz.ca/hexarelin-methyl-group-ghrp-6-difference/): Hexarelin differs from GHRP-6 by fourteen daltons on a single indole ring. Easy to see on a mass spectrum, easy to miss on a chromatogram run too steeply.
- [Humanin: One Free Cysteine and What It Does](https://exolabz.ca/humanin-cysteine-dimer-oxidation/): A 24-residue mitochondria-derived peptide with an unpaired cysteine and an N-terminal methionine. Why its purity figure is time-dependent in a way most are not.
- [Incretin Receptor Pharmacology: GLP-1, GIP and Glucagon Receptors](https://exolabz.ca/incretin-receptor-pharmacology-glp1-gip-glucagon/)
- [Ipamorelin and GHSR-1a: Selectivity in a Secretagogue](https://exolabz.ca/ipamorelin-ghsr-1a-selectivity/)
- [Ipamorelin: Three of Five Residues Are Not Standard](https://exolabz.ca/ipamorelin-non-standard-residues-aib/): Aib has no chirality at all. D-2-naphthylalanine supplies the only chromophore. And amino acid analysis cannot tell you whether two positions are D or L.
- [Is a Synthetic Peptide the Same Molecule as the Natural One?](https://exolabz.ca/endogenous-versus-synthetic-peptides/): At the level of the written sequence, yes. At the level of what is in the vial, several differences persist — modifications, impurity profile, stereochemistry, even isotopes.
- [Ki, IC50 and EC50: What Binding and Potency Figures Actually Measure](https://exolabz.ca/ki-ic50-ec50-binding-potency-explained/): Three numbers appear throughout the peptide literature and are routinely treated as interchangeable. They measure different things under different conditions.
- [Kisspeptin-10 and the KISS1R Signalling Pathway](https://exolabz.ca/kisspeptin-10-kiss1r-signalling/)
- [KLOW Peptide Blend: What Is In It and What Each Component Is Studied For](https://exolabz.ca/klow-peptide-blend-components-research/)
- [KPV: What Changes When a Peptide Is Only Three Residues Long](https://exolabz.ca/kpv-tripeptide-identity-analysis/): A Lys-Pro-Val tripeptide that barely retains on a C18 column, has no aromatic residue and lands in a noisy region of the mass spectrum. What confirms it instead.
- [LL-37: A Cationic Helix and What It Does to the Chromatography](https://exolabz.ca/ll-37-cathelicidin-fragment-analysis/): A 37-residue fragment of human cathelicidin carrying a net charge near plus six. Why it tails, why it adsorbs, and why the solvent changes how it folds.
- [Long R3 IGF-1: Where Peptide Analysis Becomes Protein Analysis](https://exolabz.ca/long-r3-igf-1-disulfide-folding-analysis/): Eighty-three residues, three disulfide bonds and fifteen possible cysteine pairings. Why intact mass is blind to the failure mode that matters most.
- [Melanocortin Receptor Subtypes: Why MC1R and MC4R Selectivity Matters](https://exolabz.ca/melanocortin-receptor-subtypes-selectivity/)
- [Melanotan-I, Melanotan-II and PT-141: Three Compounds, One Dalton Apart](https://exolabz.ca/melanotan-1-melanotan-2-pt-141-structural-comparison/)
- [Mitochondrial Peptides: What MOTS-c and SS-31 Research Actually Measures](https://exolabz.ca/mitochondrial-peptides-mots-c-ss-31-research/)
- [MOTS-c: What Mitochondria-Derived Actually Means](https://exolabz.ca/mots-c-mitochondria-derived-peptide-explained/)
- [Multi-Peptide Blends: What One Vial of Several Compounds Can and Cannot Tell You](https://exolabz.ca/multi-peptide-blend-vial-purity-composition/)
- [N-Terminal Acetylation and C-Terminal Amidation](https://exolabz.ca/peptide-terminal-modifications-acetylation-amidation/)
- [NAD and Cellular Energy: What a Coenzyme Is and Is Not](https://exolabz.ca/nad-coenzyme-cellular-energy-research/)
- [Peptide Half-Life: What Sets It and How Analogs Extend It](https://exolabz.ca/peptide-half-life-analog-modifications/)
- [Peptide Mapping: Protease Digestion and Sequence Coverage](https://exolabz.ca/peptide-mapping-protease-digestion/): How a protease digest confirms residue order, what sequence coverage means, and why a peptide map localises a modification that an intact mass cannot.
- [Peptide Nomenclature: Sequences, Analogs, Fragments and Salts](https://exolabz.ca/peptide-nomenclature-analogs-fragments-salts/)
- [Protecting Groups: The Mass Signatures of Incomplete Deprotection](https://exolabz.ca/protecting-groups-incomplete-deprotection-masses/): Right sequence, wrong mass. The increments that identify which side chain kept its group — and why arginine is the recurring offender.
- [PT-141: Melanocortin Selectivity and the Lactam Bridge](https://exolabz.ca/pt-141-melanocortin-selectivity-lactam-bridge/): PT-141 differs from melanotan-II by one amide group and behaves very differently at the receptor. Subtype selectivity, why the lactam bridge changes the analytics, and how to tell the two apart.
- [Reporter Gene Assays: A Signal Several Steps Removed](https://exolabz.ca/reporter-gene-assays-peptides/): Amplification buys sensitivity and costs comparability. The luciferase artefact class, what normalisation does not fix, and why a response element does not identify a receptor.
- [Resin Choice and Loading in Peptide Synthesis](https://exolabz.ca/peptide-synthesis-resin-choice-loading/): Two decisions made before the first coupling: what the chain is anchored to and how densely. Why the linker sets the C-terminus and why high loading generates deletion sequences.
- [Selank and Semax: Two Peptides Derived From Endogenous Sequences](https://exolabz.ca/selank-semax-endogenous-peptide-derivatives/)
- [Selank: Tuftsin, the Pro-Gly-Pro Tail, and a Purity Figure Worth Checking](https://exolabz.ca/selank-tuftsin-pro-gly-pro-stabilisation/)
- [Semax: What the ACTH Fragment Kept, and the 16-Dalton Peak](https://exolabz.ca/semax-acth-fragment-methionine-oxidation/)
- [Sermorelin: GHRH(1-29) and the Reference Analog](https://exolabz.ca/sermorelin-ghrh-1-29-reference-analog/): Sermorelin is the minimal fully active GHRH fragment, left unmodified. Where it is cleaved, why the C-terminal amide matters, and when the unstabilised compound is the correct tool.
- [Short Peptide Bioregulators: The Name Is Not the Sequence](https://exolabz.ca/short-peptide-bioregulators-names-sequences/): Epitalon, pinealon, vesugen, thymogen and vilon are two to four residues each. Two of them share a nominal mass, and nothing in the trade names tells you which residues.
- [Solid-Phase Peptide Synthesis: How a Sequence Is Built](https://exolabz.ca/solid-phase-peptide-synthesis-cycle/)
- [SS-31 and Cardiolipin: How a Mitochondria-Targeted Tetrapeptide Works](https://exolabz.ca/ss-31-cardiolipin-mitochondrial-targeting/)
- [Tesamorelin: A Stabilised GHRH Analog](https://exolabz.ca/tesamorelin-stabilised-ghrh-analog/)
- [The GLOW Blend: Three Components, Three Kinds of Molecule](https://exolabz.ca/glow-peptide-blend-composition-analysis/): BPC-157, TB-500 and GHK-Cu in one vial at 10:10:50. Why the copper complex changes the analysis, and why area percentage will not give you the ratio.
- [Thymosin Alpha-1: The Peptide With No 280 Nanometre Signal](https://exolabz.ca/thymosin-alpha-1-sequence-detection-mass/): A 28-residue acetylated sequence containing no tryptophan, tyrosine or phenylalanine. Why that makes 280 nm detection useless and what has to be used instead.
- [Thymosin β4 and TB-500: Why the Fragment Is Not the Protein](https://exolabz.ca/thymosin-beta-4-vs-tb-500-fragment/)
- [Vasoactive Intestinal Peptide: Four Degradation Routes in One Sequence](https://exolabz.ca/vip-peptide-sequence-degradation-routes/): VIP is 28 residues, amidated, and carries methionine, three asparagines, two aspartates and two tyrosines. A case study in why one named impurity never describes a chromatogram.
- [Vehicle Controls: The Solvent Is an Experimental Variable](https://exolabz.ca/vehicle-controls-peptide-experiments/): An untreated well is not a vehicle control. What has to match, why a concentration series is also a counter-ion series, and the controls peptides specifically require.
- [What a Cell Viability Assay Actually Measures](https://exolabz.ca/cell-viability-assays-what-they-measure/): Tetrazolium and resazurin assays measure reductive metabolic capacity, not survival. Why that is circular for mitochondrial compounds, and the artefacts that produce signal with no biology.
- [What a Third-Party Peptide Test Actually Measures](https://exolabz.ca/what-third-party-peptide-testing-measures/)
- [What a Western Blot Can and Cannot Establish](https://exolabz.ca/western-blot-limitations/): Semi-quantitative at best, and built for proteins rather than short peptides. Transfer losses, antibody specificity controls, loading controls and where the image-handling line sits.
- [Why an In Vitro Concentration Is Not a Dose](https://exolabz.ca/in-vitro-concentration-not-a-dose/): A micromolar figure in a dish is an experimental setting, not a property of an organism. The four things that break the conversion, and why the bridge cannot be built here.
- [Why BPC-157 Peaks Broaden: Three Prolines in a Row](https://exolabz.ca/bpc-157-proline-cis-trans-peak-broadening/): Proline is the only residue whose preceding bond adopts cis and trans in comparable proportions. Three consecutive ones is why a BPC-157 chromatogram looks the way it does.
- [Why Two Laboratories Get Different Results From the Same Peptide](https://exolabz.ca/reproducibility-peptide-assay-results/): Repeatability, reproducibility and replication are three questions. What differs between the vial and the well, what was never specified, and what narrows the gap.

## Delivery coverage

- [Research Peptides Canada](https://exolabz.ca/research-peptides-canada/)
- [Research Peptides in Alberta](https://exolabz.ca/research-peptides-alberta/)
- [Research Peptides in British Columbia](https://exolabz.ca/research-peptides-british-columbia/)
- [Research Peptides in Calgary](https://exolabz.ca/research-peptides-calgary/)
- [Research Peptides in Edmonton](https://exolabz.ca/research-peptides-edmonton/)
- [Research Peptides in Halifax](https://exolabz.ca/research-peptides-halifax/)
- [Research Peptides in Hamilton](https://exolabz.ca/research-peptides-hamilton/)
- [Research Peptides in London](https://exolabz.ca/research-peptides-london/)
- [Research Peptides in Manitoba](https://exolabz.ca/research-peptides-manitoba/)
- [Research Peptides in Moncton](https://exolabz.ca/research-peptides-moncton/)
- [Research Peptides in Montreal](https://exolabz.ca/research-peptides-montreal/)
- [Research Peptides in New Brunswick](https://exolabz.ca/research-peptides-new-brunswick/)
- [Research Peptides in Newfoundland and Labrador](https://exolabz.ca/research-peptides-newfoundland-labrador/)
- [Research Peptides in Nova Scotia](https://exolabz.ca/research-peptides-nova-scotia/)
- [Research Peptides in Nunavut](https://exolabz.ca/research-peptides-nunavut/)
- [Research Peptides in Ontario](https://exolabz.ca/research-peptides-ontario/)
- [Research Peptides in Ottawa](https://exolabz.ca/research-peptides-ottawa/)
- [Research Peptides in Prince Edward Island](https://exolabz.ca/research-peptides-prince-edward-island/)
- [Research Peptides in Quebec](https://exolabz.ca/research-peptides-quebec/)
- [Research Peptides in Quebec City](https://exolabz.ca/research-peptides-quebec-city/)
- [Research Peptides in Regina](https://exolabz.ca/research-peptides-regina/)
- [Research Peptides in Saskatchewan](https://exolabz.ca/research-peptides-saskatchewan/)
- [Research Peptides in Saskatoon](https://exolabz.ca/research-peptides-saskatoon/)
- [Research Peptides in the Northwest Territories](https://exolabz.ca/research-peptides-northwest-territories/)
- [Research Peptides in Toronto](https://exolabz.ca/research-peptides-toronto/)
- [Research Peptides in Vancouver](https://exolabz.ca/research-peptides-vancouver/)
- [Research Peptides in Victoria](https://exolabz.ca/research-peptides-victoria/)
- [Research Peptides in Winnipeg](https://exolabz.ca/research-peptides-winnipeg/)
- [Research Peptides in Yukon](https://exolabz.ca/research-peptides-yukon/)

## Boundary

All products are laboratory reference materials supplied for in-vitro research and analytical use by qualified purchasers. They are not drugs, natural health products, dietary supplements, foods, cosmetics or medical devices, are not authorised or approved by any regulator for use in humans or animals, and are not intended to diagnose, treat, cure, mitigate or prevent any disease or to affect the structure or any function of the body. No preparation, handling or dosing guidance is given.

_Generated 2026-09-20 from live site data._